The preovulatory LH surge in the sheep is accompanied by a massive and sustained surge of GnRH.
(Endocrinology 137: [4730] [4731] [4732] [4733] [4734] [4735] [4736] [4737] 1996) T HE PREOVULATORY gonadotropin surge in spontaneous ovulators is induced by an increase in circulating estradiol, which stimulates LH and FSH secretion by enhancing both GnRH release and pituitary responsiveness to the releasing hormone (1). The preovulatory pattern of GnRH secretion has been well characterized in sheep due to the availability of a method for sampling hypophyseal portal blood from conscious, normally behaving animals (2-5). In this species, both the spontaneous and estradiol-induced gonadotropin surges have been shown to be accompanied by a large and sustained increase in GnRH release. This GnRH surge begins coincident with the LH and FSH increase but continues for many hours after gonadotropin secretion returns to baseline (3, 4, (6) (7) (8) . A similar GnRH surge, which extends beyond the gonadotropin surge, has been described for the rhesus monkey (9), rat (10, ll), and mare (12).
The extended duration of the GnRH discharge raises an intriguing question. How much of the sustained GnRH surge is required to induce and maintain the preovulatory LH surge? Experiments employing several different approaches have led to the conclusion that in sheep, at least some of the GnRH surge is necessary (1,X3-18) . For example, when estradiol was administered to sheep in which GnRH release had been blocked, it was necessary to provide a bolus of GnRH over and above an ongoing episodic delivery of the releasing hormone for a preovulatory-like surge of LH to be induced (1). In none of these early studies, however, was the essential component of the endogenous GnRH surge determined.
The aim of this study was to determine how much of the endogenous GnRH surge is required to induce and maintain a LH surge of full amplitude and duration. Our specific focus was on the duration of the required GnRH signal. The approach was to monitor the effect of a competitive GnRH receptor antagonist administered at various times relative to the LH surge on the development and progression of the surge pattern of LH release. The hormonal profiles of a representative ewe during the artificial follicular phase of the control cycle (cycle 1) and the Nal-Glu treatment cycles (cycle 2 and 3) are illustrated in Fig.  1 . All five ewes exhibited a LH surge in response to the estradiol rise of the control cycle (Fig. 1, Zefc) . Treatment with Nal-Glu before the expected time of surge onset in cycles 2 and 3 completely blocked the LH surge; yet, all animals exhibited a robust GnRH surge as measured in cycle 3 (Fig.  1, right) . The time course and shape of the GnRH surges in cycle 3 resembled those previously observed in the artificial follicular phase model under conditions in which antagonist was not given (6, 28). These results indicate Nal-Glu effectively blocks the LH surge without interrupting the GnRH surge. This validates use of the antagonist as an approach to determine how much of the GnRH surge, in terms of duration, is needed for generation of a LH surge of full duration and amplitude.
Exp 2: duration of GnRH stimulus required for the LH surge Additional validation steps. In addition to validating the experimental approach in Exp 1,2 controls were built into the design of Exp 2. First, because the study spanned much of the breeding season (cycle 1 in October and cycle 5 in December), it was necessary to test whether the time during the breeding season affected the outcome of the study. For this purpose, 5 control animals did not receive Nal-Glu in any of the 5 artificial follicular phases (25 total surge inductions). In all instances, an unambiguous LH surge was induced. Trends were noted for increased latency from onset of the estradiol signal to initiation and peak of the LH surge between cycles 1 and 3 (October 12 to November 16), for decreased latency between cycle 3 and 5 (November 16 to December 21), for a slightly increased presurge baseline between cycles 1 and 3, and for decreased baseline between cycles 3 and 5. Across the study period, however, these trends were not statistically significant. Given the objective of this study, we do not consider time within the breeding season to be a factor.
The second additional validation step was to test whether blockade of the LH surge by the antagonist in one cycle affected subsequent generation of the LH surge. For this purpose, none of the 25 animals received antagonist treatment in cycles 1 and 3; Nal-Glu was given during the intervening cycle. All animals in both cycles 1 and 3 exhibited normal LH surges. Figure 2 compares the mean (*SE) LH concentrations during the surges in cycles 1 and 3 for the 20 animals that received Nal-Glu in cycle 2. Neither peak amplitude nor rates of ascent and descent differed significantly between cycles 1 and 3. Thus, blockade of GnRH action during cycle 2 did not affect generation of the LH surge in the subsequent cycle.
Treatment with GnRH antagonist before the surge. Nal-Glu treatment was begun before the onset of the LH surge in a total Animals did not receive antagonist treatment during either cycle 1 or 3. All animals, however, had received Nal-Glu during the intervening cycle (cycle 2). of 25 artificial follicular phases. The LH profiles from 3 representative ewes are illustrated in Fig. 3 together with data from 1 of the 2 control cycles in each animal. In every instance, LH decreased after Nal-Glu administration to a level that remained at or near assay sensitivity, and no LH surge occurred. This finding demonstrates that in the ewe, GnRH action is needed not only to sustain basal LH secretion before onset of the surge, but also to induce the LH surge.
Treatment with GnRH antagonist during the ascending limb of the LH surge. Antagonist treatment was begun during the ascending limb of the LH surge in 17 artificial follicular phases. Representative results from 3 ewes are illustrated in Fig. 4 . In each of the 17 cases, LH concentrations decreased immediately after the injection of Nal-Glu and remained low for the duration of the experiment. Comparison of treatment and control cycles suggests that the antagonist interrupted progression of the LH surge, and this response was not dependent on the time within the ascending limb that Nal-Glu treatment was begun. LH decreased precipitously in animals treated near the start (Fig. 4, cycle 16E ) as well as near the apex (Fig. 4, cycle 17D ) of the LH surge.
Treatment with GnRH antagonist during the descending limb of the LH surge. To test for an effect of Nal-Glu treatment in animals in which LH concentrations were already decreasing, the rate of decline was assessed in 2 ways: comparison of the rate within treatment cycles before and after administration of the antagonist and comparison of the rate in each treatment cycle to an equivalent period of the mean of the 2 control cycles for each individual. Overall, Nal-Glu treatment was initiated during the first half of the descending limb of the LH surge in 6 artificial follicular phases (DESC-A) and in the last half in 10 instances (DESC-B). Patterns of LH in 2 representative ewes of the DESC-A and DESC-B groups are illustrated separately in Figs. 5 and 6, respectively. The calculated rates of decline of the LH surge during treatment and control cycles are compared in Table 1 .
Treatment during the first half of the descending limb Data are plotted on a logarithmic scale and are plotted relative to the time that estradiol was raised to a peak follicular phase level. The bar at the top of each panel indicates the period after administration of the GnRH antagonist.
consistently suppressed LH secretion and led to early termination of the LH surge (Fig. 5) . Within treatment cycles, the rate of LH decline increased after Nal-Glu treatment (from 21.8% to 49.7%/h, pre-VS. post-Nal-Glu; P < 0.005; Table 1 , DESC-A group). A similar significant difference was noted between equivalent periods of the treatment and control cycles. Namely, although the rates did not differ before Nal-Glu (21.8% VS. 1&5%/h, treatment VS. control cycles), the fall in LH was accelerated after Nal-Glu administration (49.7% vs. 35.8%, treatment Us. control cycles; P < 0.01). Similar results were observed in the second half of the descending limb of the LH surge (DESC-B group). Nal-Glu again caused premature termination of the LH surge (Fig. 6) . As in the animals treated during the first half of the descending limb, the rate of decline within treatment cycles also accelerated after antagonist treatment (from 37.3% to 47.1%/h, pre-VS. post-Nal-Glu; P < 0.01; Table 1 , DESC-B group). Further, although the rate of decline between treatment and control cycles did not differ during the pretreatment period (37.3% VS. 34.0%/h, treatment VS. control cycles), LH concentrations fell faster once Nal-Glu was administered (47.1% VS. 28.9%/h, treatment VS. control cycles; P < 0.001). 
Discussion
In this study, ewes were treated with a competitive GnRH receptor antagonist at various times relative to the GnRH / LH surge to examine the duration of the endogenous GnRH signal required for expression of a normal LH surge. As GnRH action is a receptor-mediated event, the LH surge should end prematurely if the antagonist were applied while continued GnRH support is needed for progression of the LH surge. Our results demonstrate that blockade of GnRH action at any point during the LH surge, even near the end of the descending limb, caused premature termination of the surge. This supports the conclusion that in the ewe, GnRH action is required throughout the duration of the LH surge for a full surge to occur.
Due to the complex nature of the hormonal feedback systems involved in generation of the LH surge (long, short, and possibly ultra short loop feedback), a crucial aspect of a study such as this is the selection of an appropriate model. Specifically, it is essential to ensure that any changes in the characteristics of the observed LH surge are due to manipulation of the variable of interest, in this case the effective duration of the endogenous GnRH signal, and not artifacts resulting from a more general perturbation of the hypothalamo-pituitary gonadal axis. For example, both estradiol and GnRH are known to affect pituitary responsiveness to GnRH (1, 2931). Therefore, both have the potential to influence the characteristics of the LH surge. Thus, it was critical to use an experimental model in which these components are not affected by the experimental treatments. The integrity of the surge-inducing estradiol signal was guaranteed by the use of the artificial follicular phase model (19). In this model, the estradiol signal for the LH surge is maintained, even when endogenous gonadotropin secretion is suppressed by blockade of GnRH action. In intact animals, Values are the rate of decline expressed as the percent drop per h. For each treatment cycle, the rates of decline before and after antagonist are compared both within treatment cycles and to those of the equivalent period in control cycles. Within rows and columns different superscripts indicate significant differences. Within rows: b vs. ' and b vs. f, P < 0.005; d vs. ', P < 0.01. Within columns: ' vs. f, P < 0.01; e vs. g, P < 0.001. D Nal-Glu was administered only during treatment cycles. In control cycles, post Nal-Glu data are the average rate of decline during the period equivalent to that in which animals received Nal-Glu in the treatment cycles. The increase in the rate of decline in the control animals in DESC-A can be attributed to the proximity of the time of Nal-Glu treatment in these cycles to the inflexion point at the peak. such a reduction in gonadotropin output could result in decreased estradiol production, follicular atresia, and abolition or alteration of the preovulatory surges of GnRH and LH. That GnRH secretion was not affected by antagonist treatment was confirmed in Exp 1. Endogenous GnRH surges, with amplitude and duration similar to those previously observed in the artificial follicular phase model (6), occurred in the face of antagonist treatment sufficient to block the LH surge. This confirms the recent finding that Nal-Glu blocks the LH surge in the ewe without interfering with GnRH secretion (32).
The results of previous studies conducted to identify exogenous GnRH treatment regimens capable of inducing a LH surge in the ewe are fully complementary with the present observations. Those studies all indicated that some increment of GnRH, over and above the ongoing high frequency pulses characteristic of the midfollicular phase, are needed for the production of a preovulatory-like LH surge in the ewe (1, 15-18). Nevertheless, a wide variety of GnRH treatment regimens were found to be effective, including increased pulse amplitude or frequency, or large bolus doses of GnRH. Many of these studies were conducted before full characterization of GnRH secretion at the time of the preovulatory LH surge; treatment regimens generally focused on variations in the pulsatile delivery of GnRH. However, the actual time course of GnRH delivered to the pituitary via the portal circulation during the LH surge in the follicular phase model appears to change in a highly complex fashion. Before the surge, the pattern of GnRH release is strictly episodic. At the very start of the LH surge, in either the follicular phase model or the natural follicular phase, GnRH pulses become larger, and secretion between pulses increases markedly. Thereafter, a massive and continuous elevation of GnRH persists for the remainder of the LH surge (4, 33). The results of the previous studies that tested the response to exogenous GnRH, therefore, must be interpreted with caution relative to the elucidation of the physiologically relevant portion of the endogenous GnRH surge, as they did not restore the actual patterns of GnRH secretion seen at the time of the LH surge.
Before the present work, one study did address the question of the active component of the endogenous GnRH signal in the ewe. By administering barbiturate anesthesia (presumably blocking GnRH release) at different times during the period of the LH surge, Webb et al. (13) observed that anesthesia before, but not after, the peak of the LH surge interrupted progression of the surge. They concluded that GnRH stimulation is required throughout the ascending limb of the LH surge but not during the descending limb. Our present findings are not entirely consistent with this conclusion. We found that GnRH stimulation is required not only during the ascending limb of the surge, but also after the peak and even as late as the final portion of the descending limb when LH concentrations approach baseline. Our results agree with the findings of Phillips et al. (17), who reported that the G&H-induced LH surge in the ewe was curtailed when the delivery of GnRH was stopped before the end of the LH surge. The different conclusions relating to the continued dependence upon GnRH stimulation after the LH peak probably reflect differences in experimental models. A continued dependence upon GnRH is suggested by studies in which GnRH action was controlled by either GnRH infusion or blockade of receptor activation (Ref. 17 and present study) . In contrast, a loss of dependence on GnRH after the LH peak is suggested by the study in which GnRH release was blocked pharmacologically (13). It is possible that, with the pharmacological approach, a complete blockade of GnRH secretion was not achieved. Alternatively, continued gonadotropin secretion could have been maintained by residual actions of GnRH secreted before anesthesia. A further possibility would be that G&H-stimulated LH secretion continued after application of anesthesia due to an estradiolinduced reduction in GnRH metabolism (34), thus prolonging the availability of bioactive GnRH in the absence of further peptide secretion.
Both the GnRH requirements for generation of the LH surge and the pattern of GnRH release at the time of the LH surge have also been studied in primates. Much as in the ewe, either the spontaneous or the estradiol-induced LH surge in the rhesus monkey is accompanied by a large (9, 35) and extended release of GnRH (9). In the monkey, however, preovulatory-like surges of LH can be induced by application of constant unvarying hourly pulses of GnRH to animals in which endogenous GnRH secretion is expected to have been abolished (36). Indeed, it is even possible for estradiol to induce a LH surge in such monkeys for up to 48 h after termination of pulsatile GnRH replacement (37). These data (37) are complemented by evidence that the LH surge of intact monkeys is not blocked by immunoneutralization of GnRH (38) or treatment with GnRH antagonists (39, 40) . Collectively, these findings support the conclusion that development of the LH surge in the monkey does not require enhanced GnRH secretion, and even that the LH surge in this Endo . 1996 Vol 137. No 11 primate can occur independently of any contemporaneous G&I-I input.
Studies in women using the same approach as in this study (administration of a GnRH antagonist) led to a conclusion more complementary to that which we have reached for sheep. Nal-Glu treatment during the mid-to late follicular phase of the human menstrual cycle blocked the preovulatory LH surge; concurrent administration of estradiol and GnRH overcame this blockade (41). Although the responses to antagonist administration at various stages of the LH surge were not studied, the results suggest that endogenous GnRH is required for generation of the preovulatory LH surge of the human menstrual cycle. Another study in women compared responses to different doses of Nal-Glu at different periods of the menstrual cycle, including presurge stages of the follicular phase, preovulatory gonadotropin surge, and early luteal phase (42). The antagonist inhibited LH and FSH at all cycle stages, including during the surge, again suggesting dependence upon GnRH for generation of the gonadotropin surge. Of interest, the effectiveness of NalGlu was greatest during the LH surge, a finding that led to the speculation that GnRH secretion is decreased at this time of the human menstrual cycle. It is unfortunate that methods for direct measurement of GnRH in women are not currently available to assess this speculation, because it is at odds with the large increase in GnRH secretion observed by direct measurements in other species, including another primate (2-4, 6-12, 28, 35) .
Although the present results allow conclusions relative to the duration of the G&I-l signal needed to generate the LH surge in the ewe, they do not address several other important questions related to the massive and sustained release of GnRH that accompanies the LH surge. How much of the GnRH surge in terms of amplitude is needed to produce a full LH surge? Is there a specific qualitative change (e.g. interpulse secretion) in the pattern of GnRH secretion that is responsible for initiating the LH surge? What role, if any, is served by the large quantity of GnRH released after the LH surge has ended? With respect to the amplitude of the GnRH signal, preliminary results from our laboratory suggest that the massive release of GnRH during the surge is far in excess of that required to generate a full LH surge in the ewe (43). Whether there is a specific aspect of the GnRH signal (e.g. a change in pulse amplitude, frequency, or interpulse secretion) that initiates the LH surge has not yet been systematically examined. Nevertheless, the minute to minute pattern of GnRH in the pituitary portal blood of the ewe appears to change from being strictly episodic to continuously elevated at the very onset of the LH surge in either the natural or artificial follicular phase, raising the possibility that sustained stimulation may be critical (4).
With regard to the physiological significance of the prolonged GnRH surge, which can persist for up to 28 h in the ewe (3, 6, 28, 32, 44) , the present study attributes function for the first 8-12 h, ensuring generation of a full LH surge. This, however, may be an overestimate of the physiologically relevant duration, as it is not known how much of the LH surge is required for ovulation and development of normal postovulatory ovarian function. Any role for the latter half of the GnRH surge remains unknown. Suggested roles include stimulation of reproductive behavior, the secondary FSH surge, and gonadotropin biosynthesis in preparation for the subsequent gonadotropin surge. Although not directly addressing these points, the present study offers insight into the third possibility. The similarity of the LH surges induced in control cycles 1 and 3 (the latter of which followed Nal-Glu blockade) suggests that the extended portion of the G&I-I surge is not required for repletion of gonadotropin stores in preparation for the subsequent gonadotropin surge. A role for restoration of gonadotropins during the intervening luteal phase, however, cannot be ruled out.
A final aspect of the present study is noteworthy. Given the divergence in termination of the LH and GnRH surges and the demonstration that the LH surge does not end because of secretion of a less bioactive form of GnRH (32), it has been postulated that changes at the level of the pituitary gland cause termination of the LH surge. Suggested changes include desensitization to the stimulatory actions of GnRH and/or depletion of secretable LH from the pituitary (32, (45) (46) (47) (48) (49) . The present results indicate that antagonism of GnRH action during the descent of the LH surge, even near its very end, caused premature termination of the LH surge. Thus, although pituitary desensitization and gonadotropin depletion may well be major factors involved in the demise of the LH surge, at least some GnRH receptors capable of stimulating LH release remain active throughout the full period of the LH surge.
To summarize, the results of this study demonstrate that GnRH stimulation of the pituitary gland of sheep is required throughout the duration of the LH surge for induction of a LH surge of normal amplitude and duration. Blockade of GnRH receptor action before the LH surge or at any point during its ascending or descending limbs terminates further LH release and prevents generation of a full LH surge.
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